WallStreetZenWallStreetZen

NASDAQ: SMTI
Sanara Medtech Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Sanara Medtech revenue was $86.67M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $26.3M, up 21.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SMTI annual revenue was $86.7M, with 33.4% growth year-over-year.

SMTI past revenue growth

How has SMTI's revenue growth performed historically?

Company
33.36%
Industry
9.74%
Market
20.68%
SMTI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SMTI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SMTI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SMTI revenue history

Current Revenue
$86.7M
Current Earnings
-$9.7M
Current Profit Margin
-11.2%

Be the first to know when SMTI announces revenue.

SMTI Revenue History By Year

SMTI Yearly RevenueSMTI RevenueSMTI ChangeSMTI Revenue Growth
2024-12-31$86.67M$21.68M+33.36%
2023-12-31$64.99M$19.15M+41.77%
2022-12-31$45.84M$21.70M+89.87%
2021-12-31$24.14M$8.56M+54.90%
2020-12-31$15.59M$3.82M+32.47%
2019-12-31$11.77M$5.93M+101.56%
2018-12-31$5.84M-$466.90k-7.41%
2017-12-31$6.30M$796.89k+14.47%
2016-12-31$5.51M$2.14M+63.33%
2015-12-31$3.37M$739.55k+28.09%
2014-12-31$2.63M$906.25k+52.49%
2013-12-31$1.73M$552.85k+47.11%
2012-12-31$1.17M-$1.04M-46.89%
2011-12-31$2.21M$1.30M+142.71%
2010-12-31$910.42k$622.40k+216.10%
2009-12-31$288.02k-$2.16k-0.75%
2008-12-31$290.18k-$340.32k-53.98%
2007-12-31$630.51k$440.75k+232.27%
2006-12-31$189.76k-$21.41k-10.14%
2005-12-31$211.17k$37.08k+21.30%
2004-12-31$174.09kN/AN/A
2003-12-31$0.00-$125.00k-100.00%
2002-12-31$125.00k$104.04k+496.40%
2001-12-31$20.96k$16.37k+356.72%
2000-12-31$4.59k-$2.25M-99.80%
1999-12-31$2.25M-$573.97k-20.32%
1998-12-31$2.82M-$1.01M-26.41%
1997-12-31$3.84M$851.08k+28.49%
1996-12-31$2.99M$2.23M+296.06%
1995-12-31$754.15kN/AN/A

1 of 2

Sanara Medtech Revenue FAQ

What was SMTI's revenue last quarter?

On Invalid Date, Sanara Medtech (NASDAQ: SMTI) reported Q4 2024 revenue of $26.31 million up 48.7% year over year. In the same quarter last year, Sanara Medtech's revenue was $17.69 million.

What was Sanara Medtech's revenue in 2024?

Sanara Medtech's annual revenue for the twelve months ending Dec 31, 2024 was $86.67 million, a 33.36% increase year over year.

How much does Sanara Medtech make in a day?

Based on Sanara Medtech annual revenue for the past five years, SMTI makes an average of $129,992.33 per day.

What was Sanara Medtech's annual revenue growth in the past year?

As of Q2 2025, Sanara Medtech's revenue has grown 33.36% year over year. This is 23.62 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 9.74%. Sanara Medtech's revenue in the past year totaled $86.67 million.

How much does Sanara Medtech make in a year?

Sanara Medtech's revenue by year for the past five years is:
  • Sanara Medtech's revenue for the twelve months ending Dec 31, 2024 was $86.67 million, a 33.36% increase year over year.
  • Sanara Medtech's annual revenue for Dec 31, 2023 was $64.99 million, a 41.77% increase from 2022.
  • Sanara Medtech's annual revenue for 2022 was $45.84 million, a 89.87% increase from 2021.
  • Sanara Medtech's annual revenue for 2021 was $24.14 million, a 54.9% increase from 2020.
  • Sanara Medtech's annual revenue for 2020 was $15.59 million, a 32.47% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.